Redeye ceases its coverage of Magle Chemoswed due to the end of the contractual period following the voluntary delisting of the company's shares from Nasdaq First North Growth Market. Redeye will not provide research following quarterly reports or important business events for the company. Redeye’s rating and fair value range will be inactivated.
LÄS MER